It is interesting to notice the market response to CGB's price-sensitive announcements over the past years.
Are they really sensitive and bring price changes?
The current one, maybe sensitive, however, opposite to CGB management's expectation, why?
In comparison, we can examine the market responses to the non-price-sensitive announcements, such as the new issuances.
Are they really non-sensitive and bring little price changes?
The recent one, on voting results on forthcoming new issuances, may be sensitive too. Still opposite to CGB management's expectation, why?
Trust can never be destroyed by critical thinking of small shareholders.
- Forums
- ASX - By Stock
- CGB
- Ann: Export Permit Granted for Patented Canntab Hard Pill
Ann: Export Permit Granted for Patented Canntab Hard Pill, page-95
-
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)